Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis

John Varga*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)145-146
Number of pages2
JournalCurrent rheumatology reports
Volume5
Issue number2
DOIs
StatePublished - Apr 2003

Keywords

  • Bosentan
  • Epoprostenol
  • Primary Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Systemic Sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this